PIP 3 also interacts with proteins possessing a pleckstrin homology (PH) domain, such as protein kinases, including Akt and Bruton's tyrosine kinase (BTK)
On February 6, 2026, the FDA publicly announced its intent to take action against GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs being mass-marketed as similar alternatives to approved drugs
Furthermore, across several cellular models, incretin receptor agonists have been reported to suppress pro-fibrotic signalling pathways, including TGF-/Smad signalling, and NFB activation, leading to reduced expression of ECM proteins
So you can have delicious meals that won't make you feel like you're on a "diet"
Crit Care Nurs Q 34:213-217